The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumours
Year: 2020
Type: article
Study design: Clinical Trial
DOI: 10.1111/bcp.14508
Authors: Darcy B. Pooler, Dylan B. Ness, John Sarantopoulos, Nicholas Squittieri, Shoba Ravichandran, Carolyn D. Britten, Ravi K. Amaravadi, Ulka Vaishampayan, Patricia LoRusso, Geoffrey I. Shapiro, Anthony J. Olszanski, Raymond Perez, Martin Gutierrez, Mark Allen O’Rourke, Vincent Chung, James J. Lee, Lionel D. Lewis
Institutions: Dartmouth College, Dartmouth Cancer Center, The University of Texas at San Antonio Health Science Center, Novartis (United States), Medical University of South Carolina, Abramson Cancer Center, University of Pennsylvania, The Barbara Ann Karmanos Cancer Institute, Dana-Farber Cancer Institute, Fox Chase Cancer Center, University of Kansas Medical Center, Hackensack University Medical Center, Prisma Health, City Of Hope National Medical Center, UPMC Hillman Cancer Center
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
Funder: Novartis Pharma
OpenAlex ID: W3046595440